Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,242,135,802
+$455,346,153 QoQ
Shares Held
1,035,605
+21.1% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#73
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $6,352,612,055 across 16 Drug Manufacturers - General names. LLY ranks #2 (19.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
27,357,486 | $1,576,338,337 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
1,035,605 | $1,242,135,802 | |
| 3 | MRK |
Merck & Co., Inc.
|
8,134,262 | $1,045,252,665 | |
| 4 | JNJ |
Johnson & Johnson
|
2,907,803 | $738,494,723 | |
| 5 | ABBV |
AbbVie Inc.
|
2,015,238 | $507,114,486 | |
| 6 | PFE |
Pfizer Inc
|
18,557,891 | $446,874,011 | |
| 7 | BIIB |
Biogen Inc.
|
1,936,859 | $418,477,751 | |
| 8 | AMGN |
Amgen Inc
|
300,007 | $108,638,532 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,242,135,802 | 1,035,605 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $786,789,649 | 855,420 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $544,689,784 | 506,839 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $344,251,866 | 451,182 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $270,477,418 | 346,975 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $468,706,398 | 567,503 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $497,124,768 | 643,944 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $600,345,722 | 677,637 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $429,649,888 | 474,552 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $314,630,361 | 404,430 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $195,823,229 | 335,935 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $164,164,653 | 305,633 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $142,656,681 | 304,185 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $113,737,956 | 331,192 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $137,674,738 | 376,325 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $156,205,534 | 483,085 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $174,544,681 | 538,336 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $249,176,550 | 870,121 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $269,948,701 | 977,296 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $207,863,669 | 899,648 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $218,815,186 | 953,360 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $200,049,471 | 1,070,814 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $243,162,354 | 1,440,194 | Shares | Other | 2021-02-16 | |
| 2020-09-30 | $223,055,333 | 1,506,927 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $219,591,735 | 1,337,506 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $203,749,993 | 1,468,786 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||